CLINICAL TRIALS PROFILE FOR PRAZIQUANTEL

All Clinical Trials for praziquantel

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00215267 ↗	The Effect of Praziquantel Treatment on Schistosoma Mansoni Morbidity and re-Infection Along Lake Victoria, Uganda	Completed	Ministry of Health, Uganda	N/A	2005-09-01	The overall objective of the project is to contribute to an increased knowledge about the effect of praziquantel on schistosomiasis related morbidity and re-infection level among communities living along Lake Victoria in Mayuge district, Uganda with the overall aim of improving the strategies for morbidity control. The study will be carried out in a high transmission area along Lake Victoria, in Mayuge district. It will be a randomised intervention study, comparing a single praziquantel treatment (40mg/kg) with two standard doses administered two weeks apart.
NCT00215267 ↗	The Effect of Praziquantel Treatment on Schistosoma Mansoni Morbidity and re-Infection Along Lake Victoria, Uganda	Completed	DBL -Institute for Health Research and Development	N/A	2005-09-01	The overall objective of the project is to contribute to an increased knowledge about the effect of praziquantel on schistosomiasis related morbidity and re-infection level among communities living along Lake Victoria in Mayuge district, Uganda with the overall aim of improving the strategies for morbidity control. The study will be carried out in a high transmission area along Lake Victoria, in Mayuge district. It will be a randomised intervention study, comparing a single praziquantel treatment (40mg/kg) with two standard doses administered two weeks apart.
NCT00231322 ↗	Influence of Transmission Season on Outcome of Treatment of Schistosoma Haematobium Infection in Mozambique	Completed	Durban University of Technology	N/A	2004-03-01	To assess the influence of seasonal variations in Schistosoma haematobium transmission on treatment outcome (morbidity and re-infection)
NCT00231322 ↗	Influence of Transmission Season on Outcome of Treatment of Schistosoma Haematobium Infection in Mozambique	Completed	Durban University of Technology South Africa	N/A	2004-03-01	To assess the influence of seasonal variations in Schistosoma haematobium transmission on treatment outcome (morbidity and re-infection)
NCT00231322 ↗	Influence of Transmission Season on Outcome of Treatment of Schistosoma Haematobium Infection in Mozambique	Completed	DBL -Institute for Health Research and Development	N/A	2004-03-01	To assess the influence of seasonal variations in Schistosoma haematobium transmission on treatment outcome (morbidity and re-infection)
NCT00276224 ↗	Iron Supplementation in Schistosomiasis and Soil Transmitted Helminths Control Programmes in Zambia	Completed	DBL -Institute for Health Research and Development	N/A	2005-09-01	The objectives of this study is: - to establish the coverage rate of weekly iron supplementation in children in intervention schools over a period of nine months - document any side effects of weeekly iron supplementation among children in intervention schools over a period of nine months asses the feasibility of incorporating the weekly iron supplementation programme into the normal school activity in intervention schools determine the extent of acceptability and support for the iron supplementation programme by staff at the health centre nearest to the intervention schools - compare the praziquantel efficacy and schistosomiasis reinfection in children in intervention schools with that of children in control schools following the introduction of weekely iron supplementation over a period of nine months - determine the impact of weekly iron supplementation on haemoglobin levels of children in intervention schools and compare with children in control schools over a period of nine months

Clinical Trial Conditions for praziquantel

Condition Name

Condition Name for praziquantel
Intervention	Trials
Schistosomiasis	15
Healthy	8
Malaria	5
Schistosomiasis Mansoni	4

Condition MeSH

Condition MeSH for praziquantel
Intervention	Trials
Schistosomiasis	26
Schistosomiasis haematobia	8
Malaria	7
Schistosomiasis mansoni	6

Clinical Trial Locations for praziquantel

Trials by Country

Trials by Country for praziquantel
Location	Trials
Uganda	6
Tanzania	6
Germany	5
Gabon	3
Kenya	3

Trials by US State

Trials by US State for praziquantel
Location	Trials
Maryland	2

Clinical Trial Progress for praziquantel

Clinical Trial Phase

Clinical Trial Phase for praziquantel
Clinical Trial Phase	Trials
Phase 4	4
Phase 3	11
Phase 2/Phase 3	4

Clinical Trial Status

Clinical Trial Status for praziquantel
Clinical Trial Phase	Trials
Completed	36
Recruiting	6
Not yet recruiting	4

Clinical Trial Sponsors for praziquantel

Sponsor Name

Sponsor Name for praziquantel
Sponsor	Trials
DBL -Institute for Health Research and Development	8
Merck KGaA, Darmstadt, Germany	6
Merck KGaA	5

Sponsor Type

Sponsor Type for praziquantel
Sponsor	Trials
Other	85
Industry	21
NIH	7